FRANCISCO JAVIER
LÓPEZ LONGO
Researcher to 2019
University of Paris-Sorbonne
París, FranciaPublications in collaboration with researchers from University of Paris-Sorbonne (1)
2020
-
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 10, pp. 963-974